Biotechnology Analysis & Statistics, November 2014 (p10)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Biotech, Protein, Biomedical, more »

271-300 of about 2 300 reports

Purchase Reports From Reputable Market Research Publishers

AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

AdvanSource Biomaterials Corporation (ASNB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary AdvanSource Biomaterials Corporation (ASB) is a biomaterial manufacturing company. The company develops polymer based materials for the medical and pharmaceutical industries. Its products include ...

  • Industries : Biomaterial
  • Countries : United States
C-Pharma, Inc. (COBI) - Financial and Strategic SWOT Analysis Review

C-Pharma, Inc. (COBI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary C-Pharma, Inc. (C-Pharma), is a publicly held biotechnology company that is engaged in the development and commercialization of therapeutic and preventative products for the treatment of hepatitis ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

Intellect Neurosciences, Inc. (ILNS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Intellect Neurosciences, Inc. (Intellect Neuro) is a biopharmaceutical company. The company discovers and develops therapeutic products for the treatment and prevention of Alzheimer's disease and ...

  • Industries : Biopharmaceutical
  • Countries : United States
KDL Biotech Ltd (KOPDRUGS) - Financial and Strategic SWOT Analysis Review

KDL Biotech Ltd (KOPDRUGS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary KDL Biotech Ltd (KDL) is a publicly held healthcare company, based in India. The company is engaged in the development of various healthcare products including diagnostics and therapeutic products, ...

  • Industries : Biotechnology
  • Countries : India, South Africa
RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary RegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. ...

  • Industries : Biopharmaceutical
  • Countries : United States
Complete Genomics, Inc. - Strategic SWOT Analysis Review

Complete Genomics, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Complete Genomics, Inc. (Complete Genomics) is a biotechnology company. The company provides human genome sequencing and analysis services. It has sequenced more than 15,000 whole human genomes ...

  • Industries : Genomics
  • Countries : United States
Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Forticell Bioscience, Inc. (Forticell) is a biotechnology company. The company develops natural biomaterials and tissue engineered cellular therapies. Its product OrCel is used to stimulate the ...

  • Industries : Biological Therapy
  • Countries : United States
Protide Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Protide Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Protide Pharmaceuticals, Inc. (Protide) is a biotechnology company. The company develops and commercializes technologies and processes in clinical cell therapy, regenerative medicine, transfusion ...

  • Industries : Biological Therapy
  • Countries : United States
Pharmicell Co., Ltd. (005690) - Financial and Strategic SWOT Analysis Review

Pharmicell Co., Ltd. (005690) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pharmicell Co., Ltd. (Pharmicell) is a biotechnology company. The company develops and commercializes stem cell therapeutics for incurable diseases such as cancer, brain and nervous system disorde ...

  • Industries : Biological Therapy
Fluidigm Corporation (FLDM) - Financial and Strategic SWOT Analysis Review

Fluidigm Corporation (FLDM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Fluidigm Corporation (Fluidigm) is a biotechnology company. The company manufactures and markets microfluidic-based chips and instrumentation for biological research. Its products and systems include ...

  • Industries : Genomics
  • Countries : United States
Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Kythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline ...

  • Industries : Biopharmaceutical
  • Countries : United States
VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

VITA 34 International AG (V3V) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Vita 34 International AG (Vita 34) is a pharmaceutical company. The company collects, prepares, processes, and stores stem cells from umbilical cord blood. Its products include vitaplus, vitaplus25, ...

  • Industries : Biological Therapy
  • Countries : Switzerland
Medinet Co., Ltd. (2370) - Financial and Strategic SWOT Analysis Review

Medinet Co., Ltd. (2370) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Medinet Co., Ltd. (Medinet) is a biotechnology company. The company conducts business through the divisions such as immuno-cell therapy and research and development. Its immuno cell therapy total ...

  • Industries : Biological Therapy
  • Countries : Japan, Australia
Aemetis, Inc. (AMTX) - Financial and Strategic SWOT Analysis Review

Aemetis, Inc. (AMTX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Aemetis, Inc. (Aemetis) is an industrial biotechnology company. The company produces and markets renewable fuels, food and feed products, and biochemicals. It concentrates on the acquisition, development ...

  • Industries : Biotechnology
  • Countries : United States
Landec Corporation (LNDC) - Financial and Strategic SWOT Analysis Review

Landec Corporation (LNDC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Landec Corporation (Landec) is a materials science company. The company uses its polymer technologies, application development and capabilities to develop and commercialize new products for its ...

  • Industries : Biomaterial
  • Countries : United States
Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

Zeltia, S.A. (ZEL) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It operates through a group of companies in biopharmaceutical and chemical sectors. Under biopharmaceutical sector it discovers and develops ...

  • Industries : Biological Therapy
  • Countries : Spain, Italy
Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary bluebird bio, Inc. (bluebird bio) is a biotechnology company. The company develops gene therapies for severe genetic and orphan diseases. Its products include LentiGlobin, Lenti D, and CAR T cells. ...

  • Industries : Biological Therapy
  • Countries : United States
Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

Gene Techno Science Co., Ltd. (4584) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Gene Techno Science Co., Ltd. (GTS) is a biotechnology company. The company develops and markets drug and antibodies for intractable diseases and rare diseases. Its products include GND-001, GND-002, ...

  • Industries : Biopharmaceutical
UMN Pharma Inc. (4584) - Financial and Strategic SWOT Analysis Review

UMN Pharma Inc. (4584) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary UMN Pharma Inc. (UMN) is a biopharmaceutical company. The company develops vaccines to cure diabetes, muscular dystrophy and influenza. Its products include UMN-0502, UMN-0501, UMN-0901 and UMN-2003. ...

  • Industries : Biopharmaceutical
  • Countries : Japan
Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review

Synageva BioPharma Corp. (GEVA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Synageva BioPharma Corp. (Synageva) is a biopharmaceutical company. The company discovers, develops and delivers medicines for patients with rare disease and unmet medical needs. Its products include ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pacific Biomarkers, Inc. - Strategic SWOT Analysis Review

Pacific Biomarkers, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pacific Biomarkers, Inc. (PBI) is a biomarker laboratory services provider. The company provides laboratory services in the drug development industry. It provides clinical trial laboratory services ...

  • Industries : Genomics
  • Countries : United States
NatureWise Biotech & Medicals Corporation (4732) - Financial and Strategic SWOT Analysis Review

NatureWise Biotech & Medicals Corporation (4732) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary NatureWise Biotech & Medicals Corporation (NBM) is a biotechnology company. The company discovers, develops and markets pharmaceutical products. Its products include nutritional supplements, skincare ...

  • Industries : Biotechnology
STRATEC Biomedical AG (SBS) - Financial and Strategic SWOT Analysis Review

STRATEC Biomedical AG (SBS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary STRATEC Biomedical AG (STRATEC) is a medical device company. The company develops and offers automated analyzer systems, software for laboratory data management, and solutions for molecular diagnostic ...

  • Industries : Biopharmaceutical
Medistem, Inc. (MEDS) - Strategic SWOT Analysis Review

Medistem, Inc. (MEDS) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Medistem, Inc. (Medistem) is a biotechnology company. The company operates in the field of discovery, development and commercialization of biological technologies. Its technologies are related ...

  • Industries : Biological Therapy
  • Countries : United States
Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Provectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 ...

  • Industries : Biopharmaceutical
  • Countries : United States
Sygnis AG (LIO1) - Financial and Strategic SWOT Analysis Review

Sygnis AG (LIO1) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Sygnis AG (SYGNIS), formerly SYGNIS Pharma AG, is a biopharmaceutical company. It is focused on the development of novel products and tools in the fields of molecular biology for the fast-growing ...

  • Industries : Genomics
CytoDyn, Inc. (CYDY) - Financial and Strategic SWOT Analysis Review

CytoDyn, Inc. (CYDY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary CytoDyn, Inc. (CytoDyn ) is a biotechnology company. It involves in research and development of therapeutic monoclonal antibodies to treat HIV/AIDS. The company operates two subsidiaries, namely, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Provectus Biopharmaceuticals, Inc. (PVCT) - Medical Equipment - Deals and Alliances Profile

Provectus Biopharmaceuticals, Inc. (PVCT) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2014
  • by Global Data

Summary Provectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 ...

  • Industries : Biopharmaceutical
  • Countries : United States
Rosetta Genomics, Ltd. (ROSG) - Medical Equipment - Deals and Alliances Profile

Rosetta Genomics, Ltd. (ROSG) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2014
  • by Global Data

Summary Rosetta Genomics, Ltd. (RGL) is a biotechnology company. The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. It provides testing services ...

  • Industries : Genomics
  • Countries : United States
Response Genetics, Inc. (RGDX) - Medical Equipment - Deals and Alliances Profile

Response Genetics, Inc. (RGDX) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2014
  • by Global Data

Summary Response Genetics, Inc. (RGI) is a molecular diagnostic company. The company develops technology for the extraction and analysis of genetic information. It has tests and panels for lung, gastric, ...

  • Industries : Genomics
  • Countries : United States
About 3 200 reports

Download Unlimited Documents from Trusted Public Sources

Biopharmaceutical Industry - Company Report, November 2014

  • Department of Health and Human Services
  • November 2014
    12 pages
  • Vaccine  

  • Africa  

    United States  

View report >

Biotechnology Markets

November 2014

Global Protein Industry

November 2014

Dna Market In Australia

November 2014

About 100 Companies

Read our Company Profiles

Primary Sources

United States

Illumina Inc.

United States

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.